TPX2-amplified is a biomarker of oxaliplatin-sensitivity of colorectal cancers (CRCs) with CIN phenotype

被引：0
|
作者：
Ueno, Shohei [1 ]
Isobe, Taichi [2 ]
Taguchi, Ryosuke [1 ]
Tsuchihashi, Kenji [1 ]
Akashi, Koichi [1 ]
Baba, Eishi [2 ]
机构：
[1] Kyushu Univ, Fac Med, Dept Med & Biosyst Sci, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Oncol & Social Med, Fukuoka, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-1065
引用
收藏
页码：487 / 487
页数：1
相关论文
共 4 条
  • [1] The amplification of TPX2 is a potential biomarker of oxaliplatin-sensitivity of colorectal cancers (CRCs) with CIN phenotype
    Ueno, Shohei
    Isobe, Taichi
    Taguchi, Ryosuke
    Tsuchihashi, Kenji
    Akashi, Koichi
    Baba, Eishi
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Colorectal cancers (CRCs) with TPX2 amplification is highly sensitive to oxaliplatin
    Ueno, Shohei
    Isobe, Taichi
    Taguchi, Ryosuke
    Yamaguchi, Kyoko
    Tsuchihashi, Kenji
    Akashi, Koichi
    Baba, Eishi
    CANCER SCIENCE, 2025, 116 : 1882 - 1882
  • [3] The amplification of TPX2 is a potential biomarker of oxaliplatin-susceptibility in colorectal cancer
    Ueno, Shohei
    Isobe, Taichi
    Taguchi, Ryosuke
    Tsuchihashi, Kenji
    Ariyama, Hiroshi
    Akashi, Koichi
    Baba, Eishi
    CANCER SCIENCE, 2023, 114 : 1449 - 1449
  • [4] PKM2 as a biomarker for sensitivity to oxaliplatin-based chemotherapy in metastatic colorectal cancer (mCRC).
    Papadaki, C.
    Saridaki, Z.
    Tzardi, M.
    Sfakianaki, M.
    Sfakiotaki, G.
    Trypaki, M.
    Messaritakis, I.
    Mavroudis, D.
    Georgoulias, V.
    Sougklakos, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
1